Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient Kidneys.
Merlin Airik1, Haley Arbore1, Elizabeth Childs1
1Division of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA.
Antioxidants (Basel, Switzerland)
|April 28, 2023
Summary
Karyomegalic interstitial nephritis (KIN) is driven by DNA damage from reactive oxygen species (ROS) in kidney cells lacking the FAN1 enzyme. Targeting ROS may offer a new treatment for this genetic kidney disease.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Karyomegalic interstitial nephritis (KIN) is a genetic adult-onset chronic kidney disease (CKD) caused by FAN1 mutations, leading to genomic instability.
- The endogenous source of DNA damage in FAN1-deficient kidneys remains unidentified.
Purpose of the Study:
- To investigate the role of reactive oxygen species (ROS) in the pathophysiology of FAN1-deficient kidneys and KIN.
- To explore potential therapeutic strategies targeting oxidative stress in KIN.
Main Methods:
- Utilized FAN1-deficient human renal tubular epithelial cells (hRTECs) and FAN1-null mice as models for KIN.
- Assessed DNA damage, oxidative stress, mitochondrial function, and kidney pathology.
- Administered a mitochondria-targeted ROS scavenger (JP4-039) and low-dose cisplatin.
Main Results:
- FAN1 deficiency causes hypersensitivity to endogenous ROS, leading to chronic oxidative and double-strand DNA damage in kidney tubular cells.
- Oxidative stress in FAN1-deficient cells impairs mitochondrial function, affecting oxidative phosphorylation and fatty acid oxidation.
- ROS scavenger treatment attenuated oxidative stress, DNA damage, and kidney injury in a mouse model of KIN.
Conclusions:
- Endogenous oxidative stress is a key driver of DNA damage and KIN pathogenesis in FAN1-deficient kidneys.
- Therapeutic modulation of kidney oxidative stress presents a promising strategy for mitigating KIN progression.
Related Concept Videos
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
The Electron Transport Chain
17.0K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.0K
ATP Synthase: Mechanism
14.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.8K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


